Catalyst Pharmaceutical Partners shares owned by Commonwealth Equity Services
Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Commonwealth Equity Services
from 13F filings
Historical chart of Commonwealth Equity Services investment in Catalyst Pharmaceutical Partners
Tip: Access up to 7 years of quarterly data
All positions including Catalyst Pharmaceutical Partners held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Catalyst Pharmaceutical Partners by Commonwealth Equity Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $1.2M | 38k | 31.43 |
| 2026-03-31 | $1.2M | 49k | 24.76 |
| 2025-12-31 | $375k | 16k | 23.34 |
| 2025-09-30 | $299k | 15k | 19.73 |
| 2025-06-30 | $818k | 38k | 21.70 |
| 2025-03-31 | $1.0M | 42k | 24.25 |
| 2024-12-31 | $821k | 39k | 20.87 |
| 2024-09-30 | $335k | 17k | 19.85 |
| 2024-06-30 | $293k | 19k | 15.50 |
| 2024-03-31 | $312k | 20k | 15.93 |
| 2023-12-31 | $340k | 20k | 16.81 |
| 2023-09-30 | $201k | 17k | 11.70 |
| 2023-06-30 | $323k | 24k | 13.46 |
| 2023-03-31 | $342k | 21k | 16.57 |
| 2022-12-31 | $376k | 20k | 18.58 |
| 2022-09-30 | $204k | 16k | 12.82 |
| 2022-06-30 | $95k | 14k | 6.94 |
| 2022-03-31 | $89k | 11k | 8.24 |
| 2021-12-31 | $87k | 13k | 6.77 |
| 2021-09-30 | $64k | 12k | 5.24 |
| 2021-06-30 | $63k | 11k | 5.70 |
| 2021-03-31 | $50k | 11k | 4.52 |
| 2020-12-31 | $41k | 12k | 3.33 |
| 2020-09-30 | $39k | 13k | 2.93 |
| 2020-06-30 | $61k | 13k | 4.58 |
| 2020-03-31 | $62k | 16k | 3.80 |
| 2019-12-31 | $61k | 16k | 3.74 |
| 2019-09-30 | $86k | 16k | 5.27 |
| 2019-06-30 | $66k | 17k | 3.81 |
| 2019-03-31 | $146k | 29k | 5.07 |
| 2018-12-31 | $53k | 28k | 1.91 |
| 2018-09-30 | $91k | 24k | 3.74 |
| 2018-06-30 | $77k | 25k | 3.10 |
| 2018-03-31 | $59k | 25k | 2.38 |
| 2017-12-31 | $97k | 25k | 3.91 |
More positions owned by Commonwealth Equity Services
View all positions for Commonwealth Equity Services
Top funds holding Catalyst Pharmaceutical Partners
View all funds holding Catalyst Pharmaceutical Partners